RT Journal Article
SR Electronic
T1 ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005527
DO 10.1136/jitc-2022-005527
VO 11
IS 2
A1 Chen, Huanhuan
A1 Yang, Keqing
A1 Pang, Lingxiao
A1 Fei, Jing
A1 Zhu, Yongliang
A1 Zhou, Jianwei
YR 2023
UL http://jitc.bmj.com/content/11/2/e005527.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.